Protocol group
medication-migraine-prevention-fremanezumab
2 protocols · 4 outcomes with evidence
Subgroups
Protocols (2)
Outcomes & scoring
pain-headache-migraine-monthly-headache-hours-any-severity-change-from-baseline-self-reported1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| medication-migraine-prevention-fremanezumab-subcutaneous-monthly | +33 | 85 | 379 |
| medication-migraine-prevention-fremanezumab-subcutaneous-quarterly | +32 | 85 | 376 |
pain-headache-migraine-monthly-moderate-to-severe-headache-days-decrease-from-baseline-percent-self-reported1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| medication-migraine-prevention-fremanezumab-subcutaneous-monthly | +36 | 85 | 379 |
| medication-migraine-prevention-fremanezumab-subcutaneous-quarterly | +35 | 85 | 376 |
pain-headache-migraine-monthly-moderate-to-severe-headache-hours-change-from-baseline-self-reported1 evidence row
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| medication-migraine-prevention-fremanezumab-subcutaneous-monthly | +39 | 85 | 379 |
| medication-migraine-prevention-fremanezumab-subcutaneous-quarterly | +37 | 85 | 376 |
| Protocol | Effect | Confidence | N |
|---|---|---|---|
| medication-migraine-prevention-fremanezumab-subcutaneous-monthly | +13 | 85 | 379 |
| medication-migraine-prevention-fremanezumab-subcutaneous-quarterly | +13 | 85 | 376 |
Path: medication › migraine › prevention › fremanezumab